DOMINARI HOLDINGS INC

Insider Trading & Executive Data

DOMH
NASDAQ
Healthcare
Biotechnology

Start Free Trial

Get the full insider signal for DOMH

14 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
14
0 in last 30 days
Buy / Sell (1Y)
6/8
Acquisitions / Dispositions
Unique Insiders (1Y)
4
Active in past year
Insider Positions
27
Current holdings
Position Status
27/0
Active / Exited
Institutional Holders
32
Latest quarter
Board Members
20

Compensation & Governance

Avg Total Compensation
$4.5M
Latest year: 2025
Executives Covered
7
Comp records available
Form 8-K Events (1Y)
4
Personnel Changes (1Y)
4
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
2
Board Appointments (1Y)
2
Board Departures (1Y)
3

Restricted Sales

Form 144 Filings (1Y)
0
Form 144 Insiders (1Y)
0
Planned Sale Shares (1Y)
0
Planned Sale Value (1Y)
$0.00
Price
$3.05
Market Cap
$49.2M
Volume
4,016.36
EPS
$7.27
Revenue
$50.8M
Employees
29
About DOMINARI HOLDINGS INC

Company Overview

Dominari Holdings Inc. (DOMH) is a Delaware holding company that has pivoted from small‑molecule biotech into a financial‑services and fintech operator, running brokerage, advisory, asset management, investment banking, sales & trading, insurance distribution (via a DFHS JV), and SPV/master‑series vehicle formation. Growth in 2024–H1 2025 has been driven by Dominari Securities and transaction/commission activity, supplemented by volatile mark‑to‑market gains on long‑term investments (notably an American Bitcoin uplift) and modest bitcoin ETF exposure. The company is small (29 FTEs at year‑end 2024), relies heavily on third‑party clearing, insurance carriers and regulatory capital regimes (SEC, FINRA, state insurance regulators, Reg BI), and remains sensitive to capital markets cycles, valuation volatility and dilution from frequent financings.

Executive Compensation Practices

Dominari’s compensation profile is equity‑heavy and growth‑stage in character: recent disclosures show a large increase in stock‑based compensation (~$26M in Q2 2025) and meaningful option/warrant grants tied to financings and one‑time advisor/management payments. Pay appears to be tied to transaction‑based revenue drivers (commissions, underwriting fees, AUM/advisory fees) and to perceived mark‑to‑market performance of long‑term investments—areas where management judgment (ASC 825/ASC 321 fair value choices) can materially affect reported results. Given limited cash and working capital dynamics, the company uses equity awards to conserve cash and to align executives with long‑term asset appreciation, but that also creates incentive to favor short‑term valuation uplifts. Expect bonus/vesting triggers to reflect deal flow, underwriting volume, and AUM growth, with potential clawback or compliance conditions given broker‑dealer regulatory oversight.

Insider Trading Considerations

As a FINRA/SEC‑registered broker‑dealer holding material nonpublic deal flow and valuation‑sensitive investments, Dominari insiders are likely subject to strict preclearance, blackout windows and internal trading policies in addition to Section 16/Form 4 reporting and potential 10b5‑1 plan usage. Because a large portion of compensation is stock‑based and the company records sizeable fair‑value swings (e.g., the American Bitcoin uplift), watch for clustered insider activity—sales after large mark‑ups or purchases ahead of financings/warrants—as these events create higher signal/noise for traders. Also monitor dilutive financings and warrant exercises (recent Feb 2025 equity/warrant raise and ongoing issuances), as insiders and affiliated parties may trade around these events; enforcement risk from securities/insurance regulators could also affect executive payouts and trigger accelerated disclosures or trading restrictions.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for DOMINARI HOLDINGS INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime